ATGGF.US Actinogen Medical Limited

Healthcare Biotechnology USA Stocks
0.0293 USD
Close of Nov 13, 2026
0.0008 0.0600
Market cap
USD 114M
P/E
-
P/B
7.73x
ROE
-72.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is ATGGF.US undervalued?

Graham number

The Graham number of Actinogen Medical Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Actinogen Medical Limited fundamental analysis

No fundamental analysis for Actinogen Medical Limited yet.

Actinogen Medical Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Actinogen Medical Limited

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and cha…

Full company profile